Skip to main content

Abstract

Chapter 3 presents main clinical and pathologic characteristics of tumors and tumor-like conditions of the prostate and seminal vesicles. Emphasis is placed on rare and recently described entities. Diagnostic pathologic and immunohistochemical features useful in differential diagnosis are key characteristics described in text and tables. Representative images illustrate both common and rare tumors and tumor-like conditions of the prostate and seminal vesicles.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Arya M, Hayne D, Brown RS, O’Donnell PJ, Mundy AR. Hemangiopericytoma of the seminal vesicle presenting with hypoglycemia. J Urol. 2001;166:992.

    Article  CAS  PubMed  Google Scholar 

  • Berney DM, Algaba F, Camparo P, Compérat E, Griffiths D, Kristiansen G, Lopez-Beltran A, Montironi R, Varma M, Egevad L. Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. Virchows Arch. 2014a;464:583–7.

    Article  CAS  PubMed  Google Scholar 

  • Berney DM, Algaba F, Camparo P, Compérat E, Griffiths D, Kristiansen G, Lopez-Beltran A, Montironi R, Varma M, Egevad L. The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists. Histopathology. 2014b;64(3):405–11. doi:10.1111/his.12284. Epub 2013 Nov 6.

    Article  PubMed  Google Scholar 

  • Biermann K, Montironi R, Lopez-Beltran A, Zhang S, Cheng L. Histopathological findings after treatment of prostate cancer using high-intensity focused ultrasound (HIFU). Prostate. 2010;70(11):1196–200.

    Article  PubMed  Google Scholar 

  • Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, Rubin MA, van der Kwast T, Amin M, Epstein JI. Contemporary grading for prostate cancer: implications for patient care. Eur Urol. 2013;63(5):892–901. doi:10.1016/j.eururo.2012.10.015.

    Article  PubMed  Google Scholar 

  • Camparo P, Egevad L, Algaba F, Berney DM, Boccon-Gibod L, Compérat E, Evans AJ, Grobholz R, Kristiansen G, Langner C, Lopez-Beltran A, Montironi R, Oliveira P, Vainer B, Varma M. Utility of whole slide imaging and virtual microscopy in prostate pathology. APMIS. 2012;120(4):298–304. doi:10.1111/j.1600-0463.2011.02872.x. Review.

    Article  PubMed  Google Scholar 

  • Capitanio U, Cheng L, Lopez-Beltran A, Scarpelli M, Freschi M, Montorsi F, Montironi R. The importance of interaction between urologists and pathologists in incidental prostate cancer management. Eur Urol. 2011;60(1):75–7.

    Article  PubMed  Google Scholar 

  • Cheng L, Bishop E, Zhou H, Maclennan GT, Lopez-Beltran A, Zhang S, Badve S, Baldridge LA, Montironi R. Lymphatic vessel density in radical prostatectomy specimens. Hum Pathol. 2008a;39(4):610–5.

    Article  PubMed  Google Scholar 

  • Cheng L, Foster SR, MacLennan GT, Lopez-Beltran A, Zhang S, Montironi R. Inflammatory myofibroblastic tumors of the genitourinary tract–single entity or continuum? J Urol. 2008b;180(4):1235–40.

    Article  PubMed  Google Scholar 

  • Cheng L, MacLennan GT, Abdul-Karim FW, Lopez-Beltran A, Montironi R. Eosinophilic metaplasia of the prostate: a newly described lesion distinct from other eosinophilic changes in prostatic epithelium. Anal Quant Cytol Histol. 2008c;30(4):226–30.

    PubMed  Google Scholar 

  • Cheng L, MacLennan GT, Lopez-Beltran A, Montironi R. Anatomic, morphologic and genetic heterogeneity of prostate cancer: implications for clinical practice. Expert Rev Anticancer Ther. 2012a;12(11):1371–4. doi:10.1586/era.12.127. No.

    Article  CAS  PubMed  Google Scholar 

  • Cheng L, Montironi R, Bostwick DG, Lopez-Beltran A, Berney DM. Staging of prostate cancer. Histopathology. 2012b;60(1):87–117. doi:10.1111/j.1365-2559.2011.04025.x. Review.

    Article  PubMed  Google Scholar 

  • Cheng L, Davidson DD, Maclennan GT, Lopez-Beltran A, Montironi R, Wang M, Tan PH, Baldridge LA, Zhang S. Atypical adenomatous hyperplasia of prostate lacks TMPRSS2-ERG gene fusion. Am J Surg Pathol. 2013;37(10):1550–4. doi:10.1097/PAS.0b013e318294e9bc.

    Article  PubMed  Google Scholar 

  • De Marzo AM, Platz EA, Epstein JI, Ali T, Billis A, Chan TY, Cheng L, Datta M, Egevad L, Ertoy-Baydar D, Farre X, Fine SW, Iczkowski KA, Ittmann M, Knudsen BS, Loda M, Lopez-Beltran A, Magi-Galluzzi C, Mikuz G, Montironi R, Pikarsky E, Pizov G, Rubin MA, Samaratunga H, Sebo T, Sesterhenn IA, Shah RB, Signoretti S, Simko J, Thomas G, Troncoso P, Tsuzuki TT, van Leenders GJ, Yang XJ, Zhou M, Figg WD, Hoque A, Lucia MS. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006;30(10):1281–91.

    Article  PubMed  Google Scholar 

  • Egevad L, Algaba F, Berney DM, Boccon-Gibod L, Compérat E, Evans AJ, Grobholz R, Kristiansen G, Langner C, Lockwood G, Lopez-Beltran A, Montironi R, Oliveira P, Schwenkglenks M, Vainer B, Varma M, Verger V, Camparo P. Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading. Virchows Arch. 2011;459(2):175–82. Epub 2011 Jun 23.

    Article  PubMed  Google Scholar 

  • Egevad L, Ahmad AS, Algaba F, Berney DM, Boccon-Gibod L, Compérat E, Evans AJ, Griffiths D, Grobholz R, Kristiansen G, Langner C, Lopez-Beltran A, Montironi R, Moss S, Oliveira P, Vainer B, Varma M, Camparo P. Standardization of Gleason grading among 337 European pathologists. Histopathology. 2013;62(2):247–56. doi:10.1111/his.12008.

    Article  PubMed  Google Scholar 

  • Epstein JI, Allsbrook WC, Amin MB, Egevad LL, Bastacky S, Lopez-Beltran A, et al. The 2005 International society of urological pathology (ISUP) consensos conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005;29:1228–42.

    Article  PubMed  Google Scholar 

  • Fain JS, Cosnow I, King BF, Zincke H, Bostwick DG. Cystosarcoma phyllodes of the seminal vesicle. Cancer. 1993;71:2055–61.

    Article  CAS  PubMed  Google Scholar 

  • Galosi AB, Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Muzzonigro G, Montironi R. Solitary fibrous tumour of the prostate identified on needle biopsy. Eur Urol. 2009;56(3):564–7.

    Article  PubMed  Google Scholar 

  • Gentile AT, Moseley HS, Quinn SF, Franzini D, Pitre TM. Leiomyoma of the seminal vesicle. J Urol. 1994;151:1027–9.

    CAS  PubMed  Google Scholar 

  • Harvey AM, Grice B, Hamilton C, Truong LD, Ro JY, Ayala AG, Zhai QJ. Diagnostic utility of P504S/p63 cocktail prostate-specific antigen, and prostatic acid phosphatase in verifying prostatic carcinoma involvement in seminal vesicles a study of 57 cases of radical prostatectomy specimens of pathologic stage pT3b. Arch Pathol Lab Med. 2010;134:983–8.

    PubMed  Google Scholar 

  • Hodges KB, Abdul-Karim FW, Wang M, Lopez-Beltran A, Montironi R, Easley S, Zhang S, Wang N, MacLennan GT, Cheng L. Evidence for transformation of fibroadenoma of the breast to malignant phyllodes tumor. Appl Immunohistochem Mol Morphol. 2009;17(4):345–50.

    Article  PubMed  Google Scholar 

  • Juhasz J, Kiss P. A hitherto undescribed case of ‘collision’ tumour: liposarcoma of the seminal vesicle and prostatic carcinoma. Int Urol Nephrol. 1978;10:185–93.

    Article  CAS  PubMed  Google Scholar 

  • Lamont JS, Hesketh PJ, de las Morenas A, Babayan RK. Primary angiosarcoma of the seminal vesicle. J Urol. 1991;146:165–7.

    CAS  PubMed  Google Scholar 

  • Laurila P, Leivo I, Makisalo H, Ruutu M, Miettinen M. Mullerian adenosarcomalike tumor of the seminal vesicle. A case report with immunohistochemical and ultrastructural observations. Arch Pathol Lab Med. 1992;116:1072–6.

    CAS  PubMed  Google Scholar 

  • Lee S, Han JS, Chang A, Ross HM, Montironi R, Yorukoglu K, Lane Z, Epstein JI. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases. Hum Pathol. 2013;44(3):427–31. doi:10.1016/j.humpath.2012.06.008.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Qian J, Montironi R, Luque RJ, Bostwick DG. Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype. Int J Surg Pathol. 2005a;13:167–73.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Eble JN, Bostwick DG. Pleomorphic giant cell carcinoma of the prostate. Arch Pathol Lab Med. 2005b;129:683–5.

    PubMed  Google Scholar 

  • Lopez-Beltran A, Mikuz G, Luque RJ, Mazzucchelli R, Montironi R. Current practice of Gleason grading of prostate carcinoma. Virchows Arch. 2006;448(2):111–8.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Cheng L, Prieto R, Blanca A, Montironi R. Lymphoepithelioma-like carcinoma of the prostate. Hum Pathol. 2009;40(7):982–7.

    Article  PubMed  Google Scholar 

  • Lopez-Beltran A, Cheng L, Blanca A, Montironi R. Cell proliferation and apoptosis in prostate needle biopsies with adenocarcinoma Gleason score 6 or 7. Anal Quant Cytol Histol. 2012a;34(2):61–5.

    PubMed  Google Scholar 

  • Lopez-Beltran A, Vidal A, Montironi R, Kirkali Z, Muñoz E, Blanca A, Cheng L. Lymphocytic vasculitis of the prostate transition zone. BJU Int. 2012b;110:1775–80. doi:10.1111/j.1464-410X.2012.11079.x.

    Article  PubMed  Google Scholar 

  • Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC, Lis R, Patnaik A, Cantley LC, Bubley G, Cordon-Cardo C, Gerald WL, Montironi R, Signoretti S, Loda M, Nardella C, Pandolfi PP. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2013;45(7):747–55. doi:10.1038/ng.2650. Epub 2013 Jun 2.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Maheshkumar P, Harper C, Sunderland GT, Conn IG. Cystic epithelial stromal tumour of the seminal vesicle. BJU Int. 2000;85:1154.

    Google Scholar 

  • Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L. PMID: 17509394 [PubMed – indexed for MEDLINE] Related Articles, Links The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Hum Pathol. 2007;38(8):1207–11.

    Article  CAS  PubMed  Google Scholar 

  • Mazur MT, Myers JL, Maddox WA. Cystic epithelial-stromal tumor of the seminal vesicle. Am J Surg Pathol. 1987;11:210–7.

    Article  CAS  PubMed  Google Scholar 

  • Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z, Montironi R. Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int. 2008;102(10):1369–74.

    PubMed  Google Scholar 

  • Mazzucchelli R, Morichetti D, Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z, Montironi R. Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int. 2009a;103(11):1464–70. Epub 2009 Feb 27. Review.

    Article  PubMed  Google Scholar 

  • Mazzucchelli R, Scarpelli M, Cheng L, Lopez-Beltran A, Galosi AB, Kirkali Z, Montironi R. Pathology of prostate cancer and focal therapy (‘male lumpectomy’). Anticancer Res. 2009b;29(12):5155–61.

    PubMed  Google Scholar 

  • Mazzucchelli R, Nesseris I, Cheng L, Lopez-Beltran A, Montironi R, Scarpelli M. Active surveillance for low-risk prostate cancer. Anticancer Res. 2010;30(9):3683–92.

    PubMed  Google Scholar 

  • Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R. Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis. Hum Pathol. 2011;42(12):1931–6.

    Article  CAS  PubMed  Google Scholar 

  • Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Spectrum of prostatic nonepithelial tumors and tumorlike conditions with spindle cell features. Anal Quant Cytol Histol. 2012a;34(3):139–44.

    PubMed  Google Scholar 

  • Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Di Primio R, Montironi R. A contemporary update on pathology reporting for urinary bladder cancer. Int J Immunopathol Pharmacol. 2012b;25(3):565–71.

    CAS  PubMed  Google Scholar 

  • Mazzucchelli R, Scarpelli M, Lopez-Beltran A, Cheng L, Di Primio R, Montironi R. Treatment effects in prostate cancer following traditional and emerging therapies. Int J Immunopathol Pharmacol. 2013a;26(2):291–8. Review.

    CAS  PubMed  Google Scholar 

  • Mazzucchelli R, Scarpelli M, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Montironi R. Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma. Cell Oncol (Dordr). 2013b;36(1):37–42. doi:10.1007/s13402-012-0111-7.

    Article  CAS  Google Scholar 

  • Montironi R, Vela Navarrete R, Lopez-Beltran A, Mazzucchelli R, Mikuz G, Bono AV. Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch. 2006a;449(1):1–13.

    Article  PubMed  Google Scholar 

  • Montironi R, Scattoni V, Mazzucchelli R, Lopez-Beltran A, Bostwick DG, Montorsi F. Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as “atypical small acinar proliferation suspicious for but not diagnostic of malignancy”). Eur Urol. 2006b;50(4):666–74.

    Article  CAS  PubMed  Google Scholar 

  • Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol. 2007;4(6):321–32.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Mazzucchelli R, Lopez-Beltran A. Pathological definition and difficulties in assessing positive margins in radical prostatectomy specimens. BJU Int. 2009a;103(3):286–8.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, Mazzucchelli R, Scarpelli M, Kirkali Z, Montorsi F. Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better. Eur Urol. 2009b;56(6):951–5.

    Article  PubMed  Google Scholar 

  • Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L. Words of wisdom. Re: peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology. Eur Urol. 2010a;58(1):180–2.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Mikuz G, Kirkali Z, Montorsi F. Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient’s pathology and clinical reports. Eur Urol. 2010b;58(3):369–73.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez-Beltran A, Cheng L, Scarpelli M. Cervical-type squamous metaplasia and myoepithelial cell differentiation in stromal tumor of the prostate. Am J Surg Pathol. 2011a;35(11):1752–4. No abstract available.

    Article  PubMed  Google Scholar 

  • Montironi R, Mazzucchelli R, Lopez-Beltran A, Scarpelli M, Cheng L. Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance. BJU Int. 2011b;108(9):1394–401. doi:10.1111/j.1464-410X.2011.010413.x. Epub 2011 Aug 26. Review.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez-Beltran A, Scarpelli M, Mazzucchelli R, Cheng L. Handling of radical prostatectomy specimens: total embedding with whole mounts, with special reference to the Ancona experience (Letter). Histopathology. 2011c;59(5):1006–10.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, Mazzucchelli R, Scarpelli M. Editorial comment to When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy? Int J Urol. 2011d;18(2):153–4. doi:10.1111/j.1442-2042.2010.02717.x.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez Beltran A, Mazzucchelli R, Cheng L, Scarpelli M. Handling of radical prostatectomy specimens: total embedding with large-format histology. Int J Breast Cancer. 2012a;2012:932784. Epub 2012 Jul 10.

    Article  PubMed Central  PubMed  Google Scholar 

  • Montironi R, Scarpelli M, Cheng L, Lopez-Beltran A, Zhou M, Montorsi F. Do not misinterpret intraductal carcinoma of the prostate as high-grade prostatic intraepithelial neoplasia! Eur Urol. 2012b;62(3):518–22. Epub 2012 Jun 5.

    Article  PubMed  Google Scholar 

  • Montironi R, Scarpelli M, Mazzucchelli R, Cheng L, Lopez-Beltran A, Montorsi F. Extent of cancer of less than 50 % in any prostate needle biopsy core: how many millimeters are there? Eur Urol. 2012c;61(4):751–6. Epub 2012 Jan 5. No abstract available.

    Article  PubMed  Google Scholar 

  • Montironi R, Cheng L, Lopez-Beltran A, Mazzucchelli R, Scarpelli M. Combined handling of prostate base/bladder neck and seminal vesicles in radical prostatectomy specimens: our approach with the whole mount technique. Histopathology. 2013a;63(3):431–5. doi:10.1111/his.12158. Epub 2013 Jun 24. No abstract available.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez-Beltran A, Cheng L, Montorsi F, Scarpelli M. Central prostate pathology review: should it be mandatory? Eur Urol. 2013;64(2):199–201; discussion 202–3. doi:10.1016/j.eururo.2013.04.002. Epub 2013 Apr 16. No abstract available.

  • Montironi R, Scarpelli M, Cheng L, Lopez-Beltran A, Montorsi F, Kirkali Z. Somatostatin receptor expression in prostate carcinoma: the urological pathologist’s role in the era of personalised medicine. Pathology. 2013c;45(1):93–6. doi:10.1097/PAT.0b013e32835bae76. No abstract available.

    Article  PubMed  Google Scholar 

  • Montironi R, Lopez-Beltran A, Cheng L, Galosi AB, Montorsi F, Scarpelli M. Seminal vesicle intraepithelial neoplasia versus basal cell hyperplasia in a seminal vesicle. Eur Urol. 2014;66(4):623–7. doi:10.1016/j.eururo.2014.02.054.

  • Montironi R, Cheng L, Lopez-Beltran A, Montironi MA, Galosi AB, Scarpelli M. A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium. Pathology. 2014b;46(1):88–91. doi:10.1097/PAT.0000000000000036.

    Article  PubMed  Google Scholar 

  • Morichetti D, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z, Montorsi F, Montironi R. Secondary neoplasms of the urinary system and male genital organs. BJU Int. 2009;104(6):770–6.

    Article  PubMed  Google Scholar 

  • Muentener M, Hailemariam S, Dubs M, Hauri D, Sulser T. Primary leiomyosarcoma of the seminal vesicle. J Urol. 2000;164:2027.

    Article  CAS  PubMed  Google Scholar 

  • Ormsby AH, Haskell R, Ruthven SE, Mylne GE. Bilateral primary seminal vesicle carcinoma. Pathology. 1996;28:196–200.

    Article  CAS  PubMed  Google Scholar 

  • Ormsby AH, Haskell R, Jones D, Goldblum JR. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases. Mod Pathol. 2000;13:46–51.

    Article  CAS  PubMed  Google Scholar 

  • Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis. Hum Pathol. 2010;41:1145–9.

    Article  CAS  PubMed  Google Scholar 

  • Rao Q, Williamson SR, Lopez-Beltran A, Montironi R, Huang W, Eble JN, Grignon DJ, Koch MO, Idrees MT, Emerson RE, Zhou XJ, Zhang S, Baldridge LA, Cheng L. Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers. Mod Pathol. 2013;26(5):725–32. doi:10.1038/modpathol.2012.229. Epub 2013 Jan.

    Article  CAS  PubMed  Google Scholar 

  • Santos LD, Wong CS, Killingsworth M. Cystadenoma of the seminal vesicle: report of a case with ultrastructural findings. Pathology. 2001;33:399–402.

    CAS  PubMed  Google Scholar 

  • Scarpelli M, Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Montironi R. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol. 2012;25(1):67–74.

    CAS  PubMed  Google Scholar 

  • Schelling LA, Williamson SR, Zhang S, Yao JL, Wang M, Huang J, Montironi R, Lopez-Beltran A, Emerson RE, Idrees MT, Osunkoya AO, Man YG, Maclennan GT, Baldridge LA, Compérat E, Cheng L. Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry. Hum Pathol. 2013;44(10):2227–33. doi:10.1016/j.humpath.2013.05.005. Epub 2013 Jul 12.

    Article  CAS  PubMed  Google Scholar 

  • Seipel AH, Delahunt B, Samaratunga H, Amin M, Barton J, Berney DM, Billis A, Cheng L, Comperat E, Evans A, Fine SW, Grignon D, Humphrey PA, Magi-Galluzzi C, Montironi R, Sesterhenn I, Srigley JR, Trpkov K, van der Kwast T, Varma M, Zhou M, Ahmad A, Moss S, Egevad L. Diagnostic criteria for ductal adenocarcinoma of the prostate. Interobserver variability among 20 expert uropathologists. Histopathology. 2014. doi:10.1111/his.12382.

  • Smith SC, Palanisamy N, Zuhlke KA, Johnson AM, Siddiqui J, Chinnaiyan AM, Kunju LP, Cooney KA, Tomlins SA. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey. Am J Surg Pathol. 2014;38(5):615–26.

    Article  PubMed  Google Scholar 

  • Ukimura O, Coleman JA, de la Taille A, Emberton M, Epstein JI, Freedland SJ, Giannarini G, Kibel AS, Montironi R, Ploussard G, Roobol MJ, Scattoni V, Jones JS. Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol. 2013;63(2):214–30. doi:10.1016/j.eururo.2012.09.033.

    Article  PubMed  Google Scholar 

  • Valerio M, Ahmed HU, Emberton M, Lawrentschuk N, Lazzeri M, Montironi R, Nguyen PL, Trachtenberg J, Polascik TJ. The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol. 2013. pii: S0302-2838(13)00557-5. doi:10.1016/j.eururo.2013.05.048.

  • Varinot J, Drouin S, Rouprêt M, Montironi R, Lopez-Beltran A, Compérat E. Prostate cancer with clear cell features and an unusual nested-like pattern of growth: a case report. Anal Quant Cytol Histol. 2012;34(5):289–92.

    Google Scholar 

  • Varma M, Berney DM, Algaba F, Camparo P, Compérat E, Griffiths DF, Kristiansen G, Lopez-Beltran A, Montironi R, Egevad L. Prostate needle biopsy processing: a survey of laboratory practice across Europe. J Clin Pathol. 2013;66(2):120–3. doi:10.1136/jclinpath-2012-200993.

    Article  PubMed  Google Scholar 

  • Wagner DG, Yao JL, di Sant’Agnese PA, Cheng L, Lopez-Beltran A, Montironi R, Huang J. Soft tissue tumors of the prostate: a review. Anal Quant Cytol Histol. 2007;29(6):341–50.

    PubMed  Google Scholar 

  • Wang X, Jones TD, Zhang S, Eble JN, Bostwick DG, Qian J, Lopez-Beltran A, Montironi R, Harris JJ, Cheng L. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate. Mod Pathol. 2007;20(2):175–82.

    Article  CAS  PubMed  Google Scholar 

  • Westra WH, Grenko RT, Epstein J. Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate. Hum Pathol. 2000;31:63–8.

    Article  CAS  PubMed  Google Scholar 

  • Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, Osunkoya AO, MacLennan GT, Montironi R, Cheng L. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol. 2011;24(8):1120–7. doi:10.1038/modpathol.2011.56.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, Maclennan GT, Cheng L. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol. 2013;37(10):1619–26. doi:10.1097/PAS.0b013e318293729d.

    Article  PubMed  Google Scholar 

  • Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. Eur Urol. 2014;65(2):303–13. doi:10.1016/j.eururo.2013.07.039. Epub 2013 Aug 3.

    Article  PubMed  Google Scholar 

  • Zhang C, Montironi R, MacLennan GT, Lopez-Beltran A, Li Y, Tan PH, Wang M, Zhang S, Iczkowski KA, Cheng L. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Prostate. 2011;71(16):1746–51. doi:10.1002/pros.21391. Epub 2011 Apr 7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lopez-Beltran, A., Menendez, C.L., Montironi, R., Cheng, L. (2015). The Prostate and Seminal Vesicles. In: Rare Tumors and Tumor-like Conditions in Urological Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-10253-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-10253-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-10252-8

  • Online ISBN: 978-3-319-10253-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics